日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A retrospective cohort study of chimeric antigen receptor T-Cell therapy in follicular lymphoma patients with or without histological transformation

一项回顾性队列研究,探讨嵌合抗原受体T细胞疗法在伴或不伴组织学转化的滤泡性淋巴瘤患者中的应用。

Wang, Jingjing; Zeng, Liangyu; Ma, Xiao; Xu, Ting; Wu, Depei; Li, Caixia

Efficacy of emapalumab in the management of anti‑CD19 chimeric antigen receptor T‑cell therapy‑associated cytokine release syndrome: A report of two cases.

emapalumab 治疗抗 CD19 嵌合抗原受体 T 细胞疗法相关细胞因子释放综合征的疗效:两例报告

Cai Wenzhi, Lu Yutong, He Haiju, Li Jiaqi, Liu Shuangzhu, Geng Hongzhi, Yang Qin, Zeng Liangyu, Wu Depei, Li Caixia

MiR-27a-3p Targets GLP1R to Regulate Differentiation, Autophagy, and Release of Inflammatory Factors in Pre-Osteoblasts via the AMPK Signaling Pathway

miR-27a-3p通过AMPK信号通路靶向GLP1R,调节前成骨细胞的分化、自噬和炎症因子的释放

Zhi Zeng,Liangyu Fei,Juntao Yang,Jun Zuo,Zelin Huang,Hao Li